StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2014 it was $324.15K.

Annual r&d expenses

PeriodPeriod endValueChange
FY2014Dec 31, 2014$324.15K–

More CannaPharmaRx figures

See a number that looks wrong?